The role of the classical complement cascade in a "body-first" mouse model of Parkinson’s disease
Year: 2026
Type: dissertation
Abstract: Age-related neurodegenerative diseases such as Parkinson’s disease (PD) impose a significant socioeconomical burden on patients, caretakers and society. With increasing life expectancy, the impact of neurodegenerative disorders is becoming even more exacerbated. Currently, only limited therapeutic tools are available for treating PD in clinical practice. These primarily focus on managing symptoms observed in the late stages of the disease rather than on addressing the underlying neurodegeneration, underscoring the need to understand the biology of PD initiation to develop improved diagnostics and treatments. Aggregation of Synuclein (Syn) and a spectrum of motor symptoms are some of the hallmarks of PD. However, the onset of motor dysfunction is preceded by an array of non-motor symptoms observed in patients decades earlier. These are correlated with the development of Syn pathology in the periphery, with the enteric nervous system (ENS) being of particular interest. Multiple studies in animal models and human patients have shown that PD pathology can spread from the periphery to the central nervous system (CNS). As a result, at least a subset of PD patients is thought to represent the “body-first” type of the disease. Understanding the molecular events that occur in the early stages when Syn pathology enters the brain can identify novel therapeutic targets to improve patient treatment. In this work, we established a novel ENS-injected mouse line to model “body-first” PD. Using these animals, we show upregulation of the classical complement cascade in the brain stem prior to the development of Syn pathology. Consequently, we show complement-dependent upregulation of CXCL10, a known chemoattractant of T cells, and infiltration of CD3-positive cells. These results suggest a pivotal role for complement in T cell recruitment to the CNS in the context of PD. Moreover, we show that inhibition of the classical complement cascade can be protective against PD pathology initiation and spreading through the body. In summary, our findings provide novel insights into the early immune changes that contribute to the progression of the disease and may support the development of new therapeutic targeting strategies in the future.
Author: Yudina, Maria
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7223504520
